News & reading

News

See all News

News

Innovatiefonds Noord-Holland markeert dertigste investering in Life Science & Health
  • Press Release
  • 9 June 2026
GlycoTreat Announces Collaboration and Licence Option Agreement with a Global Veterinary Pharmaceutical Company
  • Press release
  • 21 May 2026
GlycoTreat receives EFRO grant from Kansen voor West to support the development of Breakthrough Allergy Immunotherapy
  • Press release
  • 16 April 2025
GlycoTreat Secures Strategic Investment from Dactari to Accelerate Breakthrough Allergy Immunotherapy
  • Press release
  • Augustus 2025

Essential Reading

Carbohydrates in allergy: from disease to novel immunotherapies.
  • Trends Immunology
  • July 2021
Subcutaneous immunotherapy using modified Phl p5a-derived peptides efficiently alleviates allergic asthma in mice
  • Allergy
  • December 2019
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
  • Frontiers of Immunology
  • December 2018
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells
  • PNAS
  • March 2016
Protein-glycan interactions in the control of innate and adaptive immune responses
  • Nature Immunology
  • May 2008